𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of new oncolytic herpes simplex virus for cervical cancer therapy

✍ Scribed by Kagabu, M.; Miura, Y.; Takeshita, R.; Yoshino, N.; Sugiyama, T.

Book ID
127392014
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
85 KB
Volume
133
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development of a second-generation oncol
Development of a second-generation oncolytic Herpes simplex virus expressing TNFΞ± for cancer therapy
✍ Z. Q. Han; M. Assenberg; B. L. Liu; Y. B. Wang; G. Simpson; S. Thomas; R. S. Cof πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 225 KB

## Abstract ## Background Tumour necrosis factor alpha (TNFΞ±) therapy is a promising anti‐cancer treatment when combined with radiotherapy due to its potent radio sensitising effects, but systemic toxicity has limited its clinical use. Previously, non‐replicative adenovirus vectors have been used